000303226 001__ 303226
000303226 005__ 20250731114306.0
000303226 0247_ $$2doi$$a10.3390/jcm14144961
000303226 0247_ $$2pmid$$apmid:40725653
000303226 037__ $$aDKFZ-2025-01577
000303226 041__ $$aEnglish
000303226 082__ $$a610
000303226 1001_ $$aJungert, Alexandra$$b0
000303226 245__ $$aFood Tolerance and Quality of Eating After Bariatric Surgery-An Observational Study of a German Obesity Center.
000303226 260__ $$aBasel$$bMDPI$$c2025
000303226 3367_ $$2DRIVER$$aarticle
000303226 3367_ $$2DataCite$$aOutput Types/Journal article
000303226 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1753941137_19396
000303226 3367_ $$2BibTeX$$aARTICLE
000303226 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000303226 3367_ $$00$$2EndNote$$aJournal Article
000303226 500__ $$a#LA:B440#
000303226 520__ $$aBackground: Bariatric surgeries, specifically laparoscopic sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB), are a common intervention for morbid obesity, significantly affecting food tolerance and quality of eating. Understanding these changes is crucial for improving postoperative care and long-term success. Methods: This observational study at University Hospital Mannheim involved 91 patients, aged between 18 and 65 year, who underwent SG or RYGB between 2009 and 2019. Food tolerance was assessed between 25 days and 117 months after surgery using the validated score by Suter et al. (Food Tolerance Score, FTS) and an additional score evaluating tolerance to specific food groups and quality of life. Data on body composition were collected through Bioelectrical Impedance Analysis (BIA) at follow-up visits. Statistical analyses included linear mixed models to analyze the association of food tolerance with body composition changes. Results: The FTS indicated moderate or poor food tolerance in 62.6% of patients, with no significant differences between SG and RYGB. Considering the results of the additional score, food groups such as red meat, wheat products, raw vegetables, carbon dioxide, fatty foods, convenience food, and sweets were the most poorly tolerated food groups. A total of 57 of the participants had a baseline and follow-up BIA measurement. Postoperatively, a significant reduction in body weight and BMI as well as in BIA parameters (fat mass, lean mass, body cell mass, and phase angle) was found. Quality of life improved after bariatric surgery and 76.9% rated their nutritional status as good or excellent, despite possible food intolerances. Conclusions: Bariatric surgery significantly reduces weight and alters food tolerance. Despite moderate or poor food tolerance, patients reported high satisfaction with their nutritional status and quality of life. Detailed food tolerance assessments and personalized dietary follow-ups are essential for the early detection and management of postoperative malnutrition, ensuring sustained weight loss and improved health outcomes.
000303226 536__ $$0G:(DE-HGF)POF4-312$$a312 - Funktionelle und strukturelle Genomforschung (POF4-312)$$cPOF4-312$$fPOF IV$$x0
000303226 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000303226 650_7 $$2Other$$aRoux-en-Y gastric bypass
000303226 650_7 $$2Other$$abariatric surgery
000303226 650_7 $$2Other$$abioelectrical impedance analysis
000303226 650_7 $$2Other$$afood tolerance
000303226 650_7 $$2Other$$aquality of life
000303226 650_7 $$2Other$$asleeve gastrectomy
000303226 7001_ $$aFinze, Alida$$b1
000303226 7001_ $$aBetzler, Alexander$$b2
000303226 7001_ $$00000-0003-4591-1046$$aReißfelder, Christoph$$b3
000303226 7001_ $$aBlank, Susanne$$b4
000303226 7001_ $$00000-0002-8131-7397$$aOtto, Mirko$$b5
000303226 7001_ $$aVassilev, Georgi$$b6
000303226 7001_ $$0P:(DE-He78)79e2e48100b40ab9f33fb2cb119d6f07$$aBetzler, Johanna$$b7$$eLast author$$udkfz
000303226 773__ $$0PERI:(DE-600)2662592-1$$a10.3390/jcm14144961$$gVol. 14, no. 14, p. 4961 -$$n14$$p4961$$tJournal of Clinical Medicine$$v14$$x2077-0383$$y2025
000303226 909CO $$ooai:inrepo02.dkfz.de:303226$$pVDB
000303226 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)79e2e48100b40ab9f33fb2cb119d6f07$$aDeutsches Krebsforschungszentrum$$b7$$kDKFZ
000303226 9131_ $$0G:(DE-HGF)POF4-312$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vFunktionelle und strukturelle Genomforschung$$x0
000303226 9141_ $$y2025
000303226 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ CLIN MED : 2022$$d2025-01-02
000303226 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2025-01-02
000303226 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2025-01-02
000303226 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2025-01-02
000303226 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2025-01-02
000303226 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2025-01-02
000303226 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2025-01-02
000303226 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2025-01-02
000303226 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2025-01-02
000303226 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2025-01-02
000303226 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2025-01-02
000303226 9202_ $$0I:(DE-He78)B440-20160331$$kB440$$lNWG-KKE Translationale Gastrointestinale Onkologie und präklinische Modelle$$x0
000303226 9201_ $$0I:(DE-He78)B440-20160331$$kB440$$lNWG-KKE Translationale Gastrointestinale Onkologie und präklinische Modelle$$x0
000303226 980__ $$ajournal
000303226 980__ $$aVDB
000303226 980__ $$aI:(DE-He78)B440-20160331
000303226 980__ $$aUNRESTRICTED